Michael A Puskarich1, Stephen Trzeciak2, Nathan I Shapiro3, Andrew B Albers4, Alan C Heffner4, Jeffrey A Kline4, Alan E Jones5. 1. Department of Emergency Medicine, University of Mississippi Medical Center, Jackson, MS. 2. Departments of Medicine, Division of Critical Care Medicine and Emergency Medicine, Cooper University Hospital, Camden, NJ. 3. Department of Emergency Medicine and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, MA. 4. Department of Emergency Medicine, Carolinas Medical Center, Charlotte, NC. 5. Department of Emergency Medicine, University of Mississippi Medical Center, Jackson, MS. Electronic address: aejones@umc.edu.
Abstract
BACKGROUND: We sought to compare the association of whole-blood lactate kinetics with survival in patients with septic shock undergoing early quantitative resuscitation. METHODS: This was a preplanned analysis of a multicenter, ED-based, randomized, controlled trial of early sepsis resuscitation. Inclusion criteria were suspected infection, two or more systemic inflammation criteria, either systolic BP< 90 mm Hg after a fluid bolus or lactate level > 4 mM, two serial lactate measurements, and an initial lactate level > 2.0 mM. We calculated the relative lactate clearance, rate of lactate clearance, and occurrence of early lactate normalization (decline to < 2.0 mM in the first 6 h). Area under the receiver operating characteristic curve (AUC) and multivariate logistic regression were used to determine the lactate kinetic parameters that were the strongest predictors of survival. RESULTS: The analysis included 187 patients, of whom 36% (n = 68) normalized their lactate level. Overall survival was 76.5% (143 of 187 patients), and the AUC of initial lactate to predict survival was 0.64. The AUCs for relative lactate clearance and lactate clearance rate were 0.67 and 0.58, respectively. Lactate normalization was the strongest predictor of survival (adjusted OR, 5.2; 95% CI, 1.7-15.8), followed by lactate clearance ≥ 50% (OR, 4.0; 95% CI, 1.6-10.0). Lactate clearance ≥ 10% (OR, 1.6; 95% CI, 0.6-4.4) was not a significant independent predictor in this cohort. CONCLUSIONS: In patients in the ED with a sepsis diagnosis, early lactate normalization during the first 6 h of resuscitation was the strongest independent predictor of survival and was superior to other measures of lactate kinetics. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT00372502; URL: clinicaltrials.gov.
RCT Entities:
BACKGROUND: We sought to compare the association of whole-blood lactate kinetics with survival in patients with septic shock undergoing early quantitative resuscitation. METHODS: This was a preplanned analysis of a multicenter, ED-based, randomized, controlled trial of early sepsis resuscitation. Inclusion criteria were suspected infection, two or more systemic inflammation criteria, either systolic BP&lt; 90 mm Hg after a fluid bolus or lactate level &gt; 4 mM, two serial lactate measurements, and an initial lactate level &gt; 2.0 mM. We calculated the relative lactate clearance, rate of lactate clearance, and occurrence of early lactate normalization (decline to &lt; 2.0 mM in the first 6 h). Area under the receiver operating characteristic curve (AUC) and multivariate logistic regression were used to determine the lactate kinetic parameters that were the strongest predictors of survival. RESULTS: The analysis included 187 patients, of whom 36% (n = 68) normalized their lactate level. Overall survival was 76.5% (143 of 187 patients), and the AUC of initial lactate to predict survival was 0.64. The AUCs for relative lactate clearance and lactate clearance rate were 0.67 and 0.58, respectively. Lactate normalization was the strongest predictor of survival (adjusted OR, 5.2; 95% CI, 1.7-15.8), followed by lactate clearance ≥ 50% (OR, 4.0; 95% CI, 1.6-10.0). Lactate clearance ≥ 10% (OR, 1.6; 95% CI, 0.6-4.4) was not a significant independent predictor in this cohort. CONCLUSIONS: In patients in the ED with a sepsis diagnosis, early lactate normalization during the first 6 h of resuscitation was the strongest independent predictor of survival and was superior to other measures of lactate kinetics. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT00372502; URL: clinicaltrials.gov.
Authors: Tim C Jansen; Jasper van Bommel; Paul G Mulder; Alexandre P Lima; Ben van der Hoven; Johannes H Rommes; Ferdinand T F Snellen; Jan Bakker Journal: J Trauma Date: 2009-02
Authors: Ryan C Arnold; Nathan I Shapiro; Alan E Jones; Christa Schorr; Jennifer Pope; Elisabeth Casner; Joseph E Parrillo; R Phillip Dellinger; Stephen Trzeciak Journal: Shock Date: 2009-07 Impact factor: 3.454
Authors: Michael A Puskarich; Stephen Trzeciak; Nathan I Shapiro; Ryan C Arnold; Alan C Heffner; Jeffrey A Kline; Alan E Jones Journal: Acad Emerg Med Date: 2012-03 Impact factor: 3.451
Authors: Alan E Jones; Nathan I Shapiro; Stephen Trzeciak; Ryan C Arnold; Heather A Claremont; Jeffrey A Kline Journal: JAMA Date: 2010-02-24 Impact factor: 56.272
Authors: Tim C Jansen; Jasper van Bommel; F Jeanette Schoonderbeek; Steven J Sleeswijk Visser; Johan M van der Klooster; Alex P Lima; Sten P Willemsen; Jan Bakker Journal: Am J Respir Crit Care Med Date: 2010-05-12 Impact factor: 21.405
Authors: Alan E Jones; Michael D Brown; Stephen Trzeciak; Nathan I Shapiro; John S Garrett; Alan C Heffner; Jeffrey A Kline Journal: Crit Care Med Date: 2008-10 Impact factor: 7.598
Authors: Rémi Coudroy; Angéline Jamet; Jean-Pierre Frat; Anne Veinstein; Delphine Chatellier; Véronique Goudet; Severin Cabasson; Arnaud W Thille; René Robert Journal: Intensive Care Med Date: 2014-12-17 Impact factor: 17.440
Authors: Adnan Javed; Faheem W Guirgis; Sarah A Sterling; Michael A Puskarich; Jennifer Bowman; Taylor Robinson; Alan E Jones Journal: J Crit Care Date: 2017-06-23 Impact factor: 3.425
Authors: Michael A Puskarich; Jeffrey A Kline; John A Watts; Kristin Shirey; Jonathan Hosler; Alan E Jones Journal: J Crit Care Date: 2015-10-26 Impact factor: 3.425
Authors: Zachary D W Dezman; Angela C Comer; Gordon S Smith; Peter F Hu; Colin F Mackenzie; Thomas M Scalea; Jon Mark Hirshon Journal: Am J Emerg Med Date: 2018-03-07 Impact factor: 2.469